Literature DB >> 29408019

Impact of Atrial Fibrillation on Cognitive Function, Psychological Distress, Quality of Life, and Impulsiveness.

Rokas Serpytis1, Aurelija Navickaite2, Emilija Serpytiene2, Jurate Barysiene3, Germanas Marinskis3, Dalius Jatuzis4, Zaneta Petrulioniene3, Aleksandras Laucevicius3, Pranas Serpytis3.   

Abstract

OBJECTIVE: Atrial fibrillation is the most common cardiac arrhythmia and a known risk factor for cerebrovascular stroke. Atrial fibrillation and longstanding hypertension may produce ischemic lesions leading to progressive cognitive impairment. The impact of atrial fibrillation alone on cognitive impairment has not been evaluated. Our objective was to compare cognitive function, quality of life, psychological distress, and impulsiveness in people with atrial fibrillation and a matched control group.
METHODS: The study included 60 patients. The first group of patients were ≥55 years of age, with ≥5 years history of atrial fibrillation, without hypertension (or with well-controlled hypertension), without previous dementia, compared with a matched group of 30 healthy control participants. Demographic and clinical characteristics were recorded. Subjects underwent the following rating scales: Mini-Mental State Examination, Hospital Anxiety and Depression, Heart Quality of Life, and Barratt Impulsiveness Scale.
RESULTS: In the atrial fibrillation group there were 63% male (n = 19) and 37% female (n = 11) patients; the control group was 33% male (n = 10) and 67% female (n = 20). Age range was from 55 to 81 years in both groups, mean = 63.9 years (±6.4) in the atrial fibrillation group and 66.1 years (±8.0) in controls. In the atrial fibrillation group, 23.3% had primary or general education, college - 23.3% and university - 53.3%; in the control group - 20%, 23.3%, and 56.7%, respectively. Mini-Mental State Examination score was 27.6 (±1.6) in the atrial fibrillation group vs 29.5 (±0.73) in the control group (P < .0001). Anxiety disorders were observed in 20 patients (66.7%) in atrial fibrillation vs 8 patients (26.67%) in the control group (P = .009). Heart Quality of Life mean score was 1.4 (±0.65) in the atrial fibrillation and 2.6 (±0.35) in the control group (P < .0001). Physical subscale mean scores were 1.4 (±0.74) in atrial fibrillation vs 2.8 (±0.18) in the control group (P < .0001).
CONCLUSION: Individuals with atrial fibrillation are more likely to develop anxiety disorder. Cognitive status is significantly lower in the atrial fibrillation group. In comparison with healthy subjects, individuals with atrial fibrillation have worse quality of life.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Atrial fibrillation; Cognitive function; Quality of life

Mesh:

Year:  2018        PMID: 29408019     DOI: 10.1016/j.amjmed.2017.12.044

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  Cognitive Impairment Is Independently Associated with Non-Adherence to Antithrombotic Therapy in Older Patients with Atrial Fibrillation.

Authors:  Hyun-Joo Seong; Kyounghoon Lee; Bo-Hwan Kim; Youn-Jung Son
Journal:  Int J Environ Res Public Health       Date:  2019-07-29       Impact factor: 3.390

2.  Symptom Severity and Health-Related Quality of Life in Patients with Atrial Fibrillation: Findings from the Observational ARENA Study.

Authors:  Monika Sadlonova; Jochen Senges; Jonas Nagel; Christopher Celano; Caroline Klasen-Max; Martin Borggrefe; Ibrahim Akin; Dierk Thomas; Christopher Jan Schwarzbach; Thomas Kleeman; Steffen Schneider; Matthias Hochadel; Tim Süselbeck; Harald Schwacke; Angelika Alonso; Markus Haass; Karl-Heinz Ladwig; Christoph Herrmann-Lingen
Journal:  J Clin Med       Date:  2022-02-21       Impact factor: 4.241

3.  Angiotensin receptor-neprilysin inhibitor therapy and recurrence of atrial fibrillation after radiofrequency catheter ablation: A propensity-matched cohort study.

Authors:  Youzheng Dong; Shucai Xiao; Jinwu He; Kaixin Shi; Si Chen; Deping Liu; Bin Huang; Zhenyu Zhai; Juxiang Li
Journal:  Front Cardiovasc Med       Date:  2022-08-04

4.  Understanding the Burden of Atrial Fibrillation and Importance of Screening: A Global Perspective and Recommendations for Turkey.

Authors:  Dursun Aras; Erdem Birgül; Bülent Görenek; Erdem Gürkaş; Atilla Özcan Özdemir; Mehmet Akif Topçuoğlu; Erdinç Yavuz; Mehdi Zoghi
Journal:  Anatol J Cardiol       Date:  2022-09       Impact factor: 1.475

5.  Exploring Depressive Symptoms and Anxiety Among Patients With Atrial Fibrillation and/or Flutter at the Time of Cardioversion or Ablation.

Authors:  Theresa A Koleck; Shazia A Mitha; Angelo Biviano; Billy A Caceres; Elizabeth J Corwin; Isaac Goldenthal; Ruth Masterson Creber; Meghan Reading Turchioe; Kathleen T Hickey; Suzanne Bakken
Journal:  J Cardiovasc Nurs       Date:  2021 Sep-Oct 01       Impact factor: 2.468

6.  Cardiac symptom burden and arrhythmia recurrence drives digital health use: results from the iHEART randomized controlled trial.

Authors:  Ruth M Masterson Creber; Meghan Reading Turchioe; Angelo Biviano; Billy Caceres; Hasan Garan; Isaac Goldenthal; Theresa Koleck; Shazia Mitha; Kathleen Hickey; Suzanne Bakken
Journal:  Eur J Cardiovasc Nurs       Date:  2022-03-03       Impact factor: 3.908

7.  Patient activation for self-management is associated with health status in patients with atrial fibrillation.

Authors:  Pamela J McCabe; Lynette G Stuart-Mullen; Christopher J McLeod; Thomas O Byrne; Monika M Schmidt; Megan E Branda; Joan M Griffin
Journal:  Patient Prefer Adherence       Date:  2018-09-25       Impact factor: 2.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.